Related Experiment Video
Updated: Aug 14, 2026

A Mouse Model of Hemorrhagic Transformation Induced by Acute Hyperglycemia Combined with Transient Focal Ischemia
Published on: November 15, 2024
Cerebral hyperperfusion syndrome
Walther N K A van Mook1, Roger J M W Rennenberg, Geert Willem Schurink
1Department of Internal Medicine and Intensive Care, University Hospital Maastricht, Maastricht, Netherlands. wvm@sint.azm.nl
Insights
Cerebral hyperperfusion syndrome (CHS) after carotid endarterectomy is a serious condition. Early recognition and treatment are crucial to prevent severe complications like brain edema and hemorrhage.
Area of Science:
- Neurology
- Vascular Surgery
- Neurosurgery
Background:
- Cerebral hyperperfusion syndrome (CHS) is a rare but serious complication following carotid endarterectomy.
- CHS is characterized by headache, hypertension, seizures, and neurological deficits, potentially leading to severe outcomes like brain edema or hemorrhage.
- Physician awareness of CHS and its management is limited, despite its significant morbidity and mortality.
Purpose of the Study:
- To review the incidence, risk factors, pathogenesis, and treatment of cerebral hyperperfusion syndrome (CHS) after carotid endarterectomy.
- To emphasize the importance of early diagnosis and intervention for CHS to prevent severe neurological complications.
- To highlight the need for increased physician awareness and knowledge regarding CHS.
Main Methods:
- Review of existing literature on cerebral hyperperfusion syndrome (CHS) post-carotid endarterectomy.
- Analysis of reported incidences, clinical presentations, and risk factors associated with CHS.
- Synthesis of current understanding regarding the pathophysiology and treatment strategies for CHS.
Main Results:
- CHS occurs in 0-3% of patients after carotid endarterectomy, primarily in those with >100% increase in cerebral perfusion.
- Key risk factors include diminished cerebrovascular reserve, postoperative hypertension, and prolonged hyperperfusion.
- Impaired cerebral autoregulation due to endothelial dysfunction and free radical generation is implicated in CHS pathogenesis.
Conclusions:
- Effective management of CHS involves regulating blood pressure and limiting cerebral perfusion increases.
- While mild CHS cases may resolve completely, severe cases can lead to disability or death.
- Enhanced physician knowledge and prompt treatment are essential to mitigate the severe consequences of CHS.
Abstract:
Cerebral hyperperfusion syndrome (CHS) after carotid endarterectomy is characterised by ipsilateral headache, hypertension, seizures, and focal neurological deficits. If not treated properly it can result in severe brain oedema, intracerebral or subarachnoid haemorrhage, and death. Knowledge of CHS among physicians is limited. Most studies report incidences of CHS of 0-3% after carotid endarterectomy. CHS is most common in patients with increases of more than 100% in perfusion compared with baseline after carotid endarterectomy and is rare in patients with increases in perfusion less than 100% compared with baseline. The most important risk factors in CHS are diminished cerebrovascular reserve, postoperative hypertension, and hyperperfusion lasting more than several hours after carotid endarterectomy. Impaired autoregulation as a result of endothelial dysfunction mediated by generation of free oxygen radicals is implicated in the pathogenesis of CHS. Treatment strategies are directed towards regulation of blood pressure and limitation of rises in cerebral perfusion. Complete recovery happens in mild cases, but disability and death can occur in more severe cases. More information about CHS and early institution of adequate treatment are of paramount importance in order to prevent these potentially severe complications.
Related Concept Videos
Cerebral Edema ll: Pathophysiology
Increased Intracranial Pressure ll: Pathophysiology
Increased Intracranial Pressure l: Introduction
Cytotoxic Edema: Pathophysiology
Hemorrhagic Stroke ll: Pathophysiology
Cerebral Edema l: Introduction

